🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
HRM
$HRMY
🔒 US EquitiesHarmony Biosciences Holdings, I
AVG HISTORICAL GAP
+1.10%
MAX GAP RECORD
+13.29%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $HRMY
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$HRMY
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 04, 2026 Earnings Release 2026-08-04 (UNDETERMINED) |
+0.00%
|
| May 07, 2026 Earnings Release 2026-05-07 (BEFORE OPEN) |
-11.68%
|
| Feb 24, 2026 Earnings Release 2026-02-24 (BEFORE OPEN) |
+2.94%
|
| Nov 04, 2025 Earnings Release 2025-11-04 (AFTER CLOSE) |
-1.27%
|
| Aug 05, 2025 Earnings Release 2025-08-05 (BEFORE OPEN) |
-3.69%
|
| May 06, 2025 Earnings Release 2025-05-06 (BEFORE OPEN) |
+3.84%
|
| Feb 25, 2025 Earnings Release 2025-02-25 (AFTER CLOSE) |
-2.54%
|
| Oct 29, 2024 Earnings Release 2024-10-29 (AFTER CLOSE) |
-9.64%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
5.7%
Bullish Gaps (7)
Bearish Gaps (6)
Neutral / Flat (0)
📖 Intelligence Summary
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗